Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
-
12.12.21
17.84%
16.02.21

Higher risks for its business
Increased challenges to pay loans and raise capital
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Enzon Pharmaceuticals

Start price
Target price
Perf. (%)
€0.15
12.12.20
€1.00
12.12.21
134.67%
13.08.21

vTv Therapeutics Inc

Start price
Target price
Perf. (%)
€2.30
12.12.20
€1.00
12.12.21
-14.22%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€3.78
12.12.20
€2.00
12.12.21
4.76%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Immutep LTD ADR

Start price
Target price
Perf. (%)
€2.78
12.12.20
€1.00
12.12.21
18.71%
26.06.21

SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€6.60
12.12.20
€3.00
12.12.21
63.18%
26.06.21

Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€392.75
11.12.20
€250.00
0.97%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Invitae Corp

Start price
Target price
Perf. (%)
€48.87
11.12.20
€50.00
-14.92%
17.12.20

Johnson & Johnson

Start price
Target price
Perf. (%)
€125.64
11.12.20
-
11.12.21
0.60%
11.12.20

Inovio Pharma

Start price
Target price
Perf. (%)
€9.35
10.12.20
€7.00
10.12.21
20.86%
20.02.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Immutep LTD ADR

Start price
Target price
Perf. (%)
€5.85
10.12.20
€5.00
-20.34%
10.12.20

Could be very worthwhile Investment >20% year
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€6.57
10.12.20
€5.00
0.52%
14.12.20

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€197.70
10.12.20
-
10.12.21
-27.04%
09.04.21

buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.92
10.12.20
€3.00
10.12.21
19.79%
10.12.21

buy
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€106.00
09.12.20
€240.00
09.12.21
-30.19%
10.12.21

Curis Inc.

Start price
Target price
Perf. (%)
€5.90
09.12.20
€4.00
7.63%
14.12.20

Risky Investment
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.94
08.12.20
-
08.12.21
19.84%
11.12.20

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.24
08.12.20
-
08.12.21
-2.57%
14.12.20

Curis Inc.

Start price
Target price
Perf. (%)
€5.60
08.12.20
-
82.14%
15.01.21

Curis Inc.

Start price
Target price
Perf. (%)
€5.05
08.12.20
-
08.12.21
137.82%
02.06.21

Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.56
08.12.20
-
6.64%
10.12.20

Risky Investment
Curis Inc.

Start price
Target price
Perf. (%)
€4.96
08.12.20
€5.00
28.02%
12.12.20

Curis Inc.

Start price
Target price
Perf. (%)
€2.80
08.12.20
-
126.79%
14.12.20

buy
Epigenomics AG NA

Start price
Target price
Perf. (%)
€0.47
07.12.20
-
07.12.21
-5.16%
10.02.21